Latest Content

With safety and efficacy profiles aligning with its brand-name formulation, this new patch could be key for women struggling with hormone therapy adherence.

Investigators link oversight with eroding trust in health authorities and call on future pandemic inquiries to weigh trade-offs.

Lara Zakaria, PharmD, MS, CNS, FMCP, illustrates the breadth of health technology going in and out of community pharmacy practice.

Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.

Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.

Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.

AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.

Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.

Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.

In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.

Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.

Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.

Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.

During American Pharmacists Month, pharmacy teams reflect on their roles and explore ways to enhance patient care.

Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.

Diabetes medication experts focus on practical access and pharmacist counseling considerations for adults on obesity medication.

The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.

Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities.

Teva Pharmaceuticals’ new olanzapine option is the first once-monthly subcutaneous injectable on the market for schizophrenia.

The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.

Melissa McGivney, PharmD, FAPhA, FCCP, discusses her career journey from her local pharmacy to a national leadership role with the American Pharmacists Association.

Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.

Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.

Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.

A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.

Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.

In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.

Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.

In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.

A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.